EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss

Houfar Sekhavat, Sara Bar Yehuda, Satish Asotra

International Journal of Molecular Sciences · 03.11.2025 · 26 (21) · 10712

DOI: 10.3390/ijms262110712 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2025. Verfasst von Houfar Sekhavat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Triple Hair Inc., Dieppe, NB E1A 7R8, Canada. Hauptthemen laut MEDLINE: Alopecia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgenetic alopecia (AGA) is the most common type of baldness, characterized by progressive miniaturization of the hair follicle and eventually atrophy. Both genetic and androgenic factors play definite roles in the pathophysiology of the disease, including androgens and growth factors, which induce a crosstalk between the dermal papilla and the hair follicle cells. The goal of AGA treatments is to prevent the hair miniaturization process; however, currently there are only two FDA-approved medications to treat AGA: topical Minoxidil (5% and 2%) for men and women, and oral Finasteride (1 mg tablets—Proscar and Propecia) for men. Nevertheless, these are costly, require lifelong treatment, and may have side effects. Thus, there have been many attempts to develop drugs that can harness the mechanisms controlling the pathogenesis of AGA. These pharmacological therapies might achieve more targeted and effective treatment for the disease. In this review, we present various treatments that have demonstrated their ability to induce hair growth by controlling the pathophysiological mechanisms involved in the development of AGA. Interestingly, treatment by a combination of some drugs has resulted in better outcomes than each of the drugs alone, hence demonstrating the advantage of activating different molecular mechanisms simultaneously.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaHumansHair FollicleMinoxidilFinasterideAnimalsMaleFemale

Stichwörter der Autor:innen

Ca2+/K channelsDHTIGF-1VEGFWnt/β-catenin pathwayandrogenetic alopeciacell cycle regulatorsfinasteridelatanoprostminoxidil

Substanzen

MinoxidilFinasteride

Autor:innen und Institutionen

  • Triple Hair Inc., Dieppe, NB E1A 7R8, Canada.

Zitieren

APA

Sekhavat, H., Bar Yehuda, S., & Asotra, S. (2025). Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss. International Journal of Molecular Sciences, 26(21), 10712. https://doi.org/10.3390/ijms262110712

Vancouver

Sekhavat H, Bar Yehuda S, Asotra S. Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss. International Journal of Molecular Sciences. 2025;26(21):10712. doi:10.3390/ijms262110712

BibTeX
@article{Sekhavat2025,
  author = {Sekhavat, Houfar and Bar Yehuda, Sara and Asotra, Satish},
  title = {Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10712},
  doi = {10.3390/ijms262110712}
}
Kostenlos starten →